Anuj Jayakar, MD, FAAP
Medical Director, Neurocritical Care Program
Dr. Anuj Jayakar is a pediatric neurologist with the Nicklaus Children’s Hospital Brain Institute and serves as medical director of the Neurocritical Care Program for acute brain dysfunction. He earned his medical degree from the Georgetown University School of Medicine in Washington, D.C. Dr. Jayakar completed a residency in pediatrics at Nicklaus Children’s Hospital, followed by a residency in pediatric neurology at Boston Children’s Hospital in Massachusetts, where he also served as chief resident. He then pursued a fellowship in pediatric epilepsy and neurophysiology at the same institution. His clinical interests include pediatric stroke, ICU EEG and management of prolonged seizures.
Dr. Jayakar is board certified in neurology with a special qualification in pediatric neurology, clinical neurophysiology and neurocritical care. He is a fellow of the American Academy of Pediatrics and member of the American Academy of Neurology, American Epilepsy Society, Child Neurology Society, Neurocritical Care Society and International Child Neurology Association. His work has been published in peer-reviewed journals and he has presented at national and global medical conferences.
Dr. Jayakar is employed by Nicklaus Children’s Pediatric Specialists (NCPS), the physician-led multispecialty medical group practice of Nicklaus Children’s Health System.
Founded in 2001, Nicklaus Children’s Hospital’s Brain Institute is one of the largest comprehensive pediatric programs dedicated solely to the care of the developing brain. It brings together world-renowned specialists in numerous pediatric neuroscience subspecialties with cumulative clinical experience unparalleled in the United States. Since 2008, the program has been ranked among the nation’s top-tier programs for pediatric neurology and neurosurgery by U.S. News & World Report. The clinical and research leadership of the program serves as a beacon to families confronting the uncertainty of a child with a brain disorder, offering the latest treatments and assessment techniques, many of which were developed by the Brain Institute team.